Bill Ackman: Venezuela Could Kill Herbalife's Earnings
Oct. 13 (Bloomberg) -- Bill Ackman, chief executive officer at Pershing Square Holdings Ltd., discusses the latest developments in the joint pursuit of Allergan with Valeant Pharmaceuticals and how Herbalife results may suffer from the currency exchange rate in Venezuela. He speaks in an exclusive interview with Bloomberg’s Hans Nichols.
Most Recent Videos
Full Show: What'd You Miss? (08/22)
15:16 - Guests include: Miller Tabak's Matt Maley and Temple University's Alexandra Guisinger. (Source: Bloomberg)